ES543646A0 - Un procedimiento para la preparacion de derivados esteroida-les - Google Patents

Un procedimiento para la preparacion de derivados esteroida-les

Info

Publication number
ES543646A0
ES543646A0 ES543646A ES543646A ES543646A0 ES 543646 A0 ES543646 A0 ES 543646A0 ES 543646 A ES543646 A ES 543646A ES 543646 A ES543646 A ES 543646A ES 543646 A0 ES543646 A0 ES 543646A0
Authority
ES
Spain
Prior art keywords
les
steroid
derivatives
procedure
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES543646A
Other languages
English (en)
Other versions
ES8606879A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of ES543646A0 publication Critical patent/ES543646A0/es
Publication of ES8606879A1 publication Critical patent/ES8606879A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
ES543646A 1983-08-25 1985-05-30 Un procedimiento para la preparacion de derivados esteroida-les Expired ES8606879A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH464483 1983-08-25

Publications (2)

Publication Number Publication Date
ES543646A0 true ES543646A0 (es) 1986-05-01
ES8606879A1 ES8606879A1 (es) 1986-05-01

Family

ID=4279973

Family Applications (2)

Application Number Title Priority Date Filing Date
ES535391A Expired ES8602844A1 (es) 1983-08-25 1984-08-24 Procedimiento para la preparacion de derivados esteroidales
ES543646A Expired ES8606879A1 (es) 1983-08-25 1985-05-30 Un procedimiento para la preparacion de derivados esteroida-les

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES535391A Expired ES8602844A1 (es) 1983-08-25 1984-08-24 Procedimiento para la preparacion de derivados esteroidales

Country Status (21)

Country Link
US (1) US4680290A (es)
EP (1) EP0135762B1 (es)
JP (1) JPS6061595A (es)
KR (1) KR850001767A (es)
AR (1) AR240834A1 (es)
AT (1) ATE37883T1 (es)
AU (1) AU574706B2 (es)
CA (1) CA1252778A (es)
DE (1) DE3474552D1 (es)
DK (1) DK347584A (es)
ES (2) ES8602844A1 (es)
FI (1) FI842830A (es)
GR (1) GR80196B (es)
HU (1) HU189929B (es)
IL (1) IL72725A (es)
MC (1) MC1618A1 (es)
NO (1) NO161679C (es)
NZ (1) NZ209275A (es)
PH (1) PH19849A (es)
PT (1) PT79130B (es)
ZA (1) ZA846430B (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1241947A (en) * 1985-05-31 1988-09-13 Pierre R. Proulx Conjugated polyene sterol derivatives as membrane probes
US5026882A (en) * 1988-12-23 1991-06-25 Smithkline Beecham Corporation Phosphinic acid substituted steroids as inhibitors of steroid 5α-reductase
US4946834A (en) * 1988-12-23 1990-08-07 Smithkline Beecham Corporation Phosphonic acid substituted steroids as steroid 5α-reductase inhibitors
US5215972A (en) * 1989-11-22 1993-06-01 Hoffmann-La Roche Inc. Steroids
CA2028759A1 (en) * 1989-11-22 1991-05-23 Jean-Marie Cassal Steroids
US5244887A (en) * 1992-02-14 1993-09-14 Straub Carl D Stanols to reduce cholesterol absorption from foods and methods of preparation and use thereof
BR9509938A (pt) * 1994-11-30 1998-01-27 Amur Research Corp Processo para aumentar a biodisponibilidade de um agente farmacéutico formulação farmacéutica para tratar um mamifero sofrendo de hipoesteroidismo osteoporose asma composição de substáncia
EP0840744A4 (en) * 1995-06-07 1999-03-10 Genta Inc CATIONIC LIPIDS BASED ON PHOSPHONIC ACID
AU701106B2 (en) 1995-06-07 1999-01-21 Promega Biosciences, Inc. Novel carbamate-based cationic lipids
EP0948341A4 (en) * 1996-09-17 2003-05-21 Supergen Inc DERIVATIVES OF PHOSPHOLIPIDIC DRUGS
US5830432A (en) * 1997-03-31 1998-11-03 Amur Pharmacuticals, Inc. Phospholipid drug derivatives
CA2330611A1 (en) 1998-05-22 1999-12-02 The Board Of Trustees Of The Leland Stanford Junior University Bifunctional molecules and therapies based thereon
AU2001234549A1 (en) 2000-01-28 2001-08-07 The Procter And Gamble Company Palatable arginine compounds and uses thereof for cardiovascular health
US20030045473A1 (en) * 2002-07-19 2003-03-06 Sarama Robert Joseph Compositions, kits, and methods for cardiovascular health
SI1889198T1 (sl) 2005-04-28 2015-02-27 Proteus Digital Health, Inc. Farma-informacijski sistem
US9062126B2 (en) 2005-09-16 2015-06-23 Raptor Pharmaceuticals Inc. Compositions comprising receptor-associated protein (RAP) variants specific for CR-containing proteins and uses thereof
AU2007327761A1 (en) * 2006-12-08 2008-06-12 Jado Technologies Gmbh Cholesterylamines for the treatment and prevention of infectious diseases
ES2728225T3 (es) 2009-02-20 2019-10-23 2 Bbb Medicines B V Sistema de administración de fármacos a base de glutatión
AU2010245823B2 (en) 2009-05-06 2016-11-24 Laboratory Skin Care, Inc. Dermal delivery compositions comprising active agent-calcium phosphate particle complexes and methods of using the same
WO2023122075A1 (en) * 2021-12-20 2023-06-29 Ohio State Innovation Foundation Compositions comprising sterol-amino-phosphate compounds and methods of making and use thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3248408A (en) * 1963-07-22 1966-04-26 Merck & Co Inc Purification of steroid phosphates

Also Published As

Publication number Publication date
AR240834A1 (es) 1991-02-28
JPS6061595A (ja) 1985-04-09
IL72725A0 (en) 1984-11-30
ZA846430B (en) 1985-04-24
MC1618A1 (fr) 1985-07-18
EP0135762A3 (en) 1986-01-22
US4680290A (en) 1987-07-14
PH19849A (en) 1986-07-22
GR80196B (en) 1985-01-02
HU189929B (en) 1986-08-28
AU574706B2 (en) 1988-07-14
ATE37883T1 (de) 1988-10-15
EP0135762A2 (de) 1985-04-03
NO161679C (no) 1989-09-13
DE3474552D1 (en) 1988-11-17
ES535391A0 (es) 1985-12-01
DK347584D0 (da) 1984-07-13
FI842830A0 (fi) 1984-07-13
NO161679B (no) 1989-06-05
PT79130A (en) 1984-09-01
ES8602844A1 (es) 1985-12-01
KR850001767A (ko) 1985-04-01
FI842830A (fi) 1985-02-26
AR240834A2 (es) 1991-02-28
IL72725A (en) 1988-07-31
DK347584A (da) 1985-02-26
CA1252778A (en) 1989-04-18
ES8606879A1 (es) 1986-05-01
NZ209275A (en) 1987-06-30
EP0135762B1 (de) 1988-10-12
HUT34997A (en) 1985-05-28
AU3222584A (en) 1985-02-28
NO843406L (no) 1985-02-26
PT79130B (en) 1986-11-14

Similar Documents

Publication Publication Date Title
ES540812A0 (es) Un procedimiento para la preparacion de nuevos derivados delaminometil-oxooxazolidinil-benceno
ES539625A0 (es) Un procedimiento para la preparacion de derivados de fenetano.
ES548672A0 (es) Un procedimiento para la preparacion de un derivado de dihi-dropiridina
ES541229A0 (es) Un procedimiento para la preparacion de nuevos derivados delcromano
ES531659A0 (es) Un procedimiento para la preparacion de nuevos derivados de arilamida
ES536525A0 (es) Un procedimiento para la preparacion de derivados de fenotiazinas.
ES535953A0 (es) Un procedimiento para la preparacion de derivados 3-cefem-4-carboxilicos.
ES543646A0 (es) Un procedimiento para la preparacion de derivados esteroida-les
ES538907A0 (es) Un procedimiento para la preparacion de derivados enol-eteres de oxicanis.
ES529462A0 (es) Un procedimiento para la preparacion de nuevos derivados de benzotiazina
ES524399A0 (es) Un procedimiento para la preparacion de derivados de milbenicina d
ES529846A0 (es) Un procedimiento para la preparacion de derivados benzoheterociclicos.
ES530668A0 (es) Un procedimiento para la preparacion de nuevos derivados de fosfolipidos
ES532172A0 (es) Un procedimiento para la preparacion de derivados de pirimidona
ES530973A0 (es) Un procedimiento para la preparacion de benzoquinolicinas
ES529213A0 (es) Un procedimiento para la preparacion de derivados de isoquinuclidina.
ES535392A0 (es) Un procedimiento para la preparacion de derivados de imidazobenzodiacepina
ES546356A0 (es) Un procedimiento para la preparacion de nuevos derivados delacido tiazolilacetico
ES540346A0 (es) Un procedimiento para la preparacion de derivados de piperi-dina
ES545776A0 (es) Un procedimiento para la preparacion de nuevos derivados de feniletanamina
ES527804A0 (es) Un procedimiento para la preparacion de derivados de oxacefalosporina
ES538697A0 (es) Un procedimiento para la preparacion de derivados de 1-normon-2-ilo
ES541840A0 (es) Un procedimiento para la preparacion de un derivado de imi- dazolilo
ES535226A0 (es) Un procedimiento para la preparacion de derivados de 2-feniletilamina.
ES531498A0 (es) Un procedimiento para la preparacion de derivados de pirimidinatriona